Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-07-25Clinical Trial Update: Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients [Phase 2]
Phase 2 trial comparing monoarticular corticosteroid injection to systemic corticosteroid administration in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2007-07-17Clinical Trial Update: The Effectiveness of a Nighttime Positioning Hand Splint in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating the effectiveness of a nighttime positioning hand splint in patients with rheumatoid arthritis. The study status is…
-
FDA approval · 2007-07-15FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
The FDA approved Granules India Ltd's supplemental application for Naproxen (naproxen sodium). This action approves a generic naproxen sodiu…
-
CLINICAL_TRIALS research · 2007-06-26Clinical Trial Update: Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists [NA]
This clinical trial update concerns using QuantiFERON-TB Gold to assess latent tuberculosis in patients with rheumatoid arthritis or spondyl…
-
FDA approval · 2007-06-20FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approves a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-06-14FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Ipca Laboratories Limited)
FDA approved Ipca Laboratories Limited's original application for hydroxychloroquine sulfate as a generic product.
-
FDA approval · 2007-06-12FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for infliximab (Remicade) submitted by Janssen Biotech, Inc. The approval updates the labeling to re…
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: The Clinical Effectiveness of Static Resting Splints in Early Rheumatoid Arthritis [NA]
The trial evaluated the clinical effectiveness of static resting splints in early rheumatoid arthritis; the study has completed.
-
FDA approval · 2007-04-30FDA Approved: METHOTREXATE — Original Application (Accord Healthcare, Inc.)
The FDA approved Accord Healthcare's original application for Methotrexate (generic).
-
CLINICAL_TRIALS other · 2007-04-27Clinical Trial Update: The Effect of Rituximab on the Humoral Response to Influenza Vaccine [NA]
A clinical trial evaluating how rituximab affects the humoral response to the influenza vaccine in rheumatoid arthritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: The Effect of Low Dose Aspirin on the Pharmacokinetics of Methotrexate
This update reports on a clinical trial evaluating how low-dose aspirin affects the pharmacokinetics of methotrexate in rheumatoid arthritis…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 4]
An open-label Phase 4 study evaluated whether adalimumab with methotrexate could reduce steroid use in active rheumatoid arthritis. The tria…
-
CLINICAL_TRIALS trial_result · 2007-04-20Clinical Trial Update: Comparison of NeuFlex and Swanson Metacarpophalangeal Implants for Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial comparing NeuFlex and Swanson metacarpophalangeal implants for rheumatoid arthritis has completed.
-
FDA approval · 2007-04-19FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab (Remicade) from Janssen Biotech, Inc., updating the product labeling per the supp…
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: Effects of Home-Based Emotional Disclosure in Rheumatoid Arthritis [Phase 2]
Phase 2 trial update evaluating whether home-based emotional disclosure impacts symptoms and quality of life in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: Omega-3 and Vitamin E Supplementation in Patients With Rheumatoid Arthritis [Phase 1]
This update reports the completion of a Phase 1 trial evaluating omega-3 fatty acids and vitamin E supplementation in patients with rheumato…
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. [Phase 2]
Phase 2 multicenter trial evaluating the efficacy of AD 452 in rheumatoid arthritis has completed.
-
FDA approval · 2007-03-29FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for MELOXICAM from Lupin Pharmaceuticals, Inc., indicating regulatory clearance for an updated l…
-
FDA approval · 2007-03-28FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for Meloxicam from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2007-03-28FDA Approved: NAPROXEN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's naproxen generic under an original ANDA, enabling market access for generic naproxen products.
-
CLINICAL_TRIALS trial_result · 2007-03-16Clinical Trial Update: Development and Evaluation of A Mailed Arthritis Self-Management Program [NA]
A completed clinical trial evaluating a mailed arthritis self-management program. It enrolled participants with osteoarthritis and rheumatoi…
-
FDA approval · 2007-03-16FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for nabumetone by Chartwell RX, LLC, indicating an additional authorization for this generic drug un…
-
FDA approval · 2007-03-13FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) from E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2007-02-22Clinical Trial Update: Treatment of Rheumatoid Arthritis With Roxithromycin [Phase 4]
A Phase 4 clinical trial evaluating roxithromycin for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS research · 2007-02-13Clinical Trial Update: Rheumatoid Arthritis Patients in Training [Phase 4]
Phase 4 clinical trial update for patients with rheumatoid arthritis. The study is sponsored by Leiden University Medical Center and the cur…